Literature DB >> 28089765

Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration.

Jessica L Cohen-Pfeffer1, Sridharan Gururangan2, Thomas Lester1, Daniel A Lim3, Adam J Shaywitz1, Manfred Westphal4, Irene Slavc5.   

Abstract

Intrathecal delivery methods have been used for many decades to treat a broad range of central nervous system disorders. A literature review demonstrated that intracerebroventricular route is an established and well-tolerated method for prolonged central nervous system drug delivery in pediatric and adult populations. Intracerebroventricular devices were present in patients from one to 7156 days. The number of punctures per device ranged from 2 to 280. Noninfectious complication rates per patient (range, 1.0% to 33.0%) were similar to infectious complication rates (0.0% to 27.0%). Clinician experience and training and the use of strict aseptic techniques have been shown to reduce the frequency of complications.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ICV; Ommaya reservoir; Rickham reservoir; complications; drug delivery; infections; intracerebroventricular; intrathecal

Mesh:

Substances:

Year:  2016        PMID: 28089765     DOI: 10.1016/j.pediatrneurol.2016.10.022

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  43 in total

1.  Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.

Authors:  M Kathryn Brewer; Annette Uittenbogaard; Grant L Austin; Dyann M Segvich; Anna DePaoli-Roach; Peter J Roach; John J McCarthy; Zoe R Simmons; Jason A Brandon; Zhengqiu Zhou; Jill Zeller; Lyndsay E A Young; Ramon C Sun; James R Pauly; Nadine M Aziz; Bradley L Hodges; Tracy R McKnight; Dustin D Armstrong; Matthew S Gentry
Journal:  Cell Metab       Date:  2019-07-25       Impact factor: 27.287

2.  Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.

Authors:  Grant L Austin; Zoe R Simmons; Jack E Klier; Alberto Rondon; Brad L Hodges; Robert Shaffer; Nadine M Aziz; Tracy R McKnight; James R Pauly; Dustin D Armstrong; Craig W Vander Kooi; Matthew S Gentry
Journal:  Mol Pharm       Date:  2019-08-02       Impact factor: 4.939

3.  Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain.

Authors:  Benjamin A Plog; Humberto Mestre; Genaro E Olveda; Amanda M Sweeney; H Mark Kenney; Alexander Cove; Kosha Y Dholakia; Jeffrey Tithof; Thomas D Nevins; Iben Lundgaard; Ting Du; Douglas H Kelley; Maiken Nedergaard
Journal:  JCI Insight       Date:  2018-10-18

Review 4.  Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Authors:  Niyanta N Kumar; Michelle E Pizzo; Geetika Nehra; Brynna Wilken-Resman; Sam Boroumand; Robert G Thorne
Journal:  Bioconjug Chem       Date:  2018-10-24       Impact factor: 4.774

5.  Troubleshooting an unusual complication following intrathecal chemotherapy delivered via Ommaya catheter: A case report.

Authors:  David J Mauler; Kent R Richter; Sarah Merrill; Cristina Valencia-Sánchez; Chandan Krishna; Maciej M Mrugala
Journal:  Mol Clin Oncol       Date:  2020-04-22

6.  Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy.

Authors:  Mahesh K Kaushik; Kosuke Aritake; Aya Imanishi; Takashi Kanbayashi; Tadashi Ichikawa; Tetsuo Shimizu; Yoshihiro Urade; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

7.  Intracerebroventricular Administration of Neural Stem Cells after Cardiac Arrest.

Authors:  Zhuoran Wang; Xiuli Yang; Junyun He; Jian Du; Shaolin Liu; Xiaofeng Jia
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2019-07

8.  Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-N-Acetylglucosamine-6-Sulfatase in Neonatal Mice.

Authors:  Feng Wang; Derek R Moen; Chelsee Sauni; Shih-Hsin Kan; Shan Li; Steven Q Le; Brett Lomenick; Xiaoyi Zhang; Sean Ekins; Srikanth Singamsetty; Jill Wood; Patricia I Dickson; Tsui-Fen Chou
Journal:  Mol Pharm       Date:  2020-12-15       Impact factor: 4.939

9.  Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers.

Authors:  Wulin Jiang; Yuchen Yang; Alison R Mercer-Smith; Alain Valdivia; Juli R Bago; Alex S Woodell; Andrew A Buckley; Michael H Marand; Li Qian; Carey K Anders; Shawn D Hingtgen
Journal:  Sci Adv       Date:  2021-06-09       Impact factor: 14.136

10.  Osmotic core-shell polymeric implant for sustained BDNF AntagoNAT delivery in CNS using minimally invasive nasal depot (MIND) approach.

Authors:  Smrithi Padmakumar; Gregory Jones; Olga Khorkova; Jane Hsiao; Jonghan Kim; Benjamin S Bleier; Mansoor M Amiji
Journal:  Biomaterials       Date:  2021-06-30       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.